Major shareholders of Newamsterdam Pharma sold shares worth $1.95 million




Major shareholders of Newamsterdam Pharma sold shares worth $1.95 million



Source link

  • Related Posts

    Dolby is targeting 15% to 20% annual growth in Atmos, Vision and Image patents as consumption-based revenue models expand.

    Dolby is targeting 15% to 20% annual growth in Atmos, Vision and Image patents as consumption-based revenue models expand. Source link

    Tinon Medical Medical (Ton) Chief Innovation Officer Geist Buys shares

    Tinon Medical Medical (Ton) Chief Innovation Officer Geist Buys shares Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *